Aryavaan Pharmaceuticals Private Limited, a active private limited company, was established on 29 September 2004 in Margao, Goa, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24100GA2004PTC007040. Registered under ROC Roc Goa. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.
Formerly known as Vastu Shining Builders Private Limited. It upholds a compliant status. Its leadership includes Krishnakumar Gangadhar Agrawal (Director), Anirudh Krishnakumar Agrawal (Director), Anurag Agrawal (Director). Past directors included Jyotiprasad Taparia, Sanjeevkumar Taparia, Satishchandra Girdharilal Sharma. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Anand Bhavan Old Station Road, Margao, Goa, 403601.
U24100GA2004PTC007040
007040
29 September 2004
₹0.50 M
₹0.20 M
Roc Goa
Unlisted
Active
Explore comprehensive insights into Aryavaan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishnakumar Gangadhar Agrawal | Director | 16 Mar 2012 | Current |
| Anirudh Krishnakumar Agrawal | Director | 16 Mar 2012 | Current |
| Anurag Agrawal | Director | 16 Mar 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Mar 2012 | Past |
| Pramod Abcsdd | Director | 16 Mar 2012 | Past |
| Pramod Abcsdd | Director | 16 Mar 2012 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Director | 16 Mar 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aryavaan Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 25% decrease. The company also saw a slight decrease in profitability, with a 3.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Aryavaan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aryavaan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aryavaan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aryavaan Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aryavaan Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was documented.
Aryavaan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Goa. was recorded as a recent event.
Krishnakumar Gangadhar Agrawal was appointed as a Director was appointed as a Director on 16 Mar 2012 & has been associated with this company since 13 years 8 months . was recorded as a recent event.
Progress on Anirudh Krishnakumar Agrawal was appointed as a Director was appointed as a Director on 16 Mar 2012 & has been associated with this company since 13 years 8 months . was documented.
The activity Anurag Agrawal was appointed as a Director was appointed as a Director on 16 Mar 2012 & has been associated with this company since 13 years 8 months . was completed.
Aryavaan Pharmaceuticals Private Limited was registered on 29 Sep 2004 with Roc Goa & aged 21 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Aryavaan Pharmaceuticals Private Limited is U24100GA2004PTC007040.
Aryavaan Pharmaceuticals Private Limited is headquartered at Anand Bhavan Old Station Road, Margao, Goa, 403601.
Aryavaan Pharmaceuticals Private Limited was incorporated on 29 September 2004.
The current directors of Aryavaan Pharmaceuticals Private Limited are
The primary industry of Aryavaan Pharmaceuticals Private Limited is Pharma.
Aryavaan Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aryavaan Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.20 M.
The compliance status of Aryavaan Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX